Related Experiment Video
Updated: Jul 11, 2026

10:05
High-throughput Detection Method for Influenza Virus
Published on: February 4, 2012
26.1K
Monitoring Influenza A Virus Entry Using Quantitative Fluorescence Microscopy
Tejal Pathak1, Kajal Gupta1, Nirmal Kumar1
1Cellular Virology Lab, Department of Biological Sciences, Indian Institute of Science Education and Research, Mohali (IISER Mohali), Mohali, Punjab, India.
Methods in Molecular Biology (Clifton, N.J.)
|January 31, 2025
Summary
Developing new influenza A virus (IAV) antivirals is crucial. This study presents fluorescence microscopy methods to monitor IAV entry, aiding the discovery of host-directed therapies.
Area of Science:
- Virology
- Cell Biology
- Microscopy
Background:
- Influenza A virus (IAV) poses a significant global health threat, necessitating urgent development of broad-spectrum antivirals.
- Inhibiting IAV host cell entry is a promising strategy to block viral replication and transcription early in infection.
- Understanding IAV entry mechanisms is key to identifying host factors as therapeutic targets.
Purpose of the Study:
- To describe fluorescence microscopy-based assays for monitoring sequential IAV entry steps.
- To provide methods for quantifying IAV entry steps using high-content microscopy.
- To facilitate the discovery of novel antivirals and host-directed therapeutic interventions.
Main Methods:
- Monitoring IAV entry from cell surface attachment to genome delivery to the nucleus using fluorescence microscopy.
- Quantifying IAV entry steps via image analysis from high-content microscopy.
- Developing quantitative assays for high-content genetic or inhibitor screens.
Main Results:
- Established fluorescence microscopy assays to track IAV entry at sequential steps.
- Developed image quantification methods for major IAV entry stages.
- Provided tools to accelerate the identification of antivirals and host targets.
Conclusions:
- Fluorescence microscopy-based IAV entry assays enhance understanding of virus-host interactions.
- These methods can lead to the discovery of novel host-directed prophylactic or therapeutic interventions against influenza.
- The described assays support high-content screening for antiviral drug discovery.

